A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma
American Journal of Cancer Research · 2025 · 15 (3) · 876-893
DOI: 10.62347/squf6988 ↗At a glance
Journal article in American Journal of Cancer Research, 2025. Written by Yingchuan Zhu and 8 co-authors. Institution: Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University Chengdu 610041, Sichuan, China. Cited 3 times so far (Crossref). The full text is freely available in PubMed Central.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
Author keywords
Authors and institutions
- Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University Chengdu 610041, Sichuan, China.
Cite
APA
Zhu, Y., Song, Y., Jiang, W., Zhang, J., Yin, L., Lin, X., Lu, Y., Tao, D., & Ma, Y. (2025). A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma. American Journal of Cancer Research, 15(3), 876-893. https://doi.org/10.62347/squf6988
Vancouver
Zhu Y, Song Y, Jiang W, Zhang J, Yin L, Lin X, et al. A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma. American Journal of Cancer Research. 2025;15(3):876-893. doi:10.62347/squf6988
BibTeX
@article{Zhu2025,
author = {Zhu, Yingchuan and Song, Yue and Jiang, Wenhao and Zhang, Jingfei and Yin, Lan and Lin, Xinyu and Lu, Yilu and Tao, Dachang and Ma, Yongxin},
title = {A novel tumor-associated macrophage risk signature predicts prognosis and immunotherapy response in lung adenocarcinoma},
journal = {American Journal of Cancer Research},
year = {2025},
volume = {15},
number = {3},
pages = {876--893},
doi = {10.62347/squf6988}
}
EUVIMED